Display options
Share it on

Ann Gastroenterol. 2016 Oct-Dec;29(4):492-496. doi: 10.20524/aog.2016.0073. Epub 2016 Jul 21.

Inflammatory bowel disease nurse specialists for patients on biological therapies: a nationwide Italian survey.

Annals of gastroenterology

Alessandra Guarini, Francesca De Marinis, Anna Kohn, Nicoletta Orzes, Renata D'Incà, Teresa Iannone, Antonella Giaquinto, Cinzia Rivara, Lorenzo Ridola, Roberto Lorenzetti, Angelo Zullo,

Affiliations

  1. Gastroenterology and Digestive Endoscopy, Nuovo Regina Margherita Hospital, Rome (Alessandra Guarini, Francesca De Marinis, Roberto Lorenzetti, Angelo Zullo).
  2. Gastroenterology Unit, San Camillo-Forlanini Hospital, Rome (Anna Kohn).
  3. Gastroenterology Unit Polo Ospedaliero Gorizia-Pordenone, Gorizia, Italy (Nicoletta Orzes).
  4. Department of Surgical, Oncological and Gastroenterological Sciences, Gastroenterology Section, University of Padua (Renata D'Incà).
  5. Gastroenterology and Digestive Endoscopy, Santa Maria degli Ungheresi Hospital, Polistena, Reggio Calabria (Teresa Iannone).
  6. Endoscopy Unit, Tor Vergata University, Rome (Antonella Giaquinto).
  7. Ciriè Hospital, Turin (Cinzia Rivara).
  8. Gastroenterology Unit, Sapienza University of Rome; Polo Pontino Hospital, Latina (Lorenzo Ridola); Italian IBD Nurses Study Group, Italy.

PMID: 27708516 PMCID: PMC5049557 DOI: 10.20524/aog.2016.0073

Abstract

BACKGROUND: Management of inflammatory bowel disease (IBD) patients requires a multidisciplinary approach. Among the working team, the role of IBD nurse is expected to be particularly relevant when managing patients receiving biological therapies. We performed a survey to assess the presence of IBD nurse in centers where patients were receiving biologics.

METHODS: For this Italian nationwide survey a specific questionnaire was prepared. IBD nurse was defined as a nurse directly involved in all phases of biological therapy, from pre-therapy screening, administration and monitoring during therapy, to follow up performed by a dedicated helpline, completed a specific training on biological therapy therapy, and observed international guidelines.

RESULTS: A total of 53 Italian IBD centers participated in the survey, and 91 valid questionnaires were collected. Overall, 34 (37.4%) nurses could be classified as IBD specialists. IBD nurses had a significantly higher educational level than other nurses, they were more frequently operating in Central or Southern than in Northern Italy, they were working in an Academic center rather than in a General hospital, and in IBD centers with >25 patients on biological therapy. On the contrary, mean age, gender distribution, years of nursing, and years working in the IBD unit did not significantly differ between IBD and other nurses.

CONCLUSIONS: Our nationwide survey showed that the presence of an IBD nurse is still lacking in the majority of Italian IBD centers where patients receive biological therapies, suggesting a prompt implementation.

Keywords: Inflammatory bowel disease; biological therapy; management; nursing

Conflict of interest statement

None

References

  1. J Crohns Colitis. 2010 Feb;4(1):28-62 - PubMed
  2. Eur J Gastroenterol Hepatol. 2000 Sep;12(9):967-73 - PubMed
  3. Dig Liver Dis. 2011 Jan;43(1):1-20 - PubMed
  4. Ann Gastroenterol. 2015 Oct-Dec;28(4):417-25 - PubMed
  5. Rev Esp Enferm Dig. 2013 May-Jun;105(5):262-71 - PubMed
  6. Ann Gastroenterol. 2014;27(2):95-104 - PubMed
  7. Ann Gastroenterol. 2013;26(1):52-58 - PubMed
  8. J Crohns Colitis. 2014 Oct;8(10):1300-7 - PubMed
  9. J Crohns Colitis. 2012 Dec;6(10):965-90 - PubMed
  10. Nurs Stand. 2007 Apr 4-10;21(30):35-40 - PubMed
  11. J Crohns Colitis. 2013 Oct;7(9):744-64 - PubMed
  12. Eur J Heart Fail. 2005 Mar 16;7(3):333-41 - PubMed
  13. Ann Gastroenterol. 2015 Jul-Sep;28(3):357-365 - PubMed
  14. J Crohns Colitis. 2010 Dec;4(6):611-22 - PubMed
  15. J Adv Nurs. 2002 Apr;38(2):152-60 - PubMed

Publication Types